Esco Lifesciences Group has acquired Evidence Solution, a software company offering IVF management technologies.

Evidence’s system is a workflow scheduling and traceability system built for IVF clinics to prevent treatment errors.

“We are excited to welcome Evidence Solution to the Esco family. Evidence Solution is a young company established in 2019. With its innovative core technologies, the company has been expanding rapidly with a steadily growing client base,” said XQ Lin, CEO of Esco Lifesciences. “IVF market is expanding rapidly, through the inclusion of Evidence’s witnessing feature to our best-in-class IVF devices, we will be able to provide our customers with more productive and compliant workflows.”